# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001485003-23-000090
Filing Date
2023-02-28
Accepted
2023-02-28 08:01:39
Documents
99
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | sesn-20221231.htm iXBRL | 10-K | 2042406
2 | EX-21.1 | exhibit211-subsidiariesofs.htm | EX-21.1 | 4209
3 | EX-23.1 | exhibit231eyfy2023consent_.htm | EX-23.1 | 10264
4 | EX-31.1 | sesn-12312022x10kex311.htm | EX-31.1 | 12364
5 | EX-31.2 | sesn-12312022x10kex312.htm | EX-31.2 | 11921
6 | EX-32.1 | sesn-12312022x10kex321.htm | EX-32.1 | 6314
7 | EX-32.2 | sesn-12312022x10kex322.htm | EX-32.2 | 6483
| Complete submission text file | 0001485003-23-000090.txt |  | 9485559

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20221231.xsd | EX-101.SCH | 66559
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sesn-20221231_cal.xml | EX-101.CAL | 83379
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sesn-20221231_def.xml | EX-101.DEF | 324762
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20221231_lab.xml | EX-101.LAB | 786689
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20221231_pre.xml | EX-101.PRE | 542340
93 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20221231_htm.xml | XML | 1495942

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36296 | Film No.: 23678466
SIC: 2834 Pharmaceutical Preparations